Rasmussen's Encephalitis

Aimee F. Luat

doi:10.1055/s-0038-1668590

Journal of Pediatric Epilepsy, Inhaltsverzeichnis

Journal of Pediatric Epilepsy 2018; 07(02): 045-051
DOI: 10.1055/s-0038-1668590

Review Article

Georg Thieme Verlag KG Stuttgart · New York

Rasmussen's Encephalitis

Aimee F. Luat

¹Carman and Ann Adams Departments of Pediatrics and Neurology, Children's Hospital of Michigan, Detroit Medical Center Wayne State University School of Medicine, Detroit, Michigan, United States

› Institutsangaben

Abstract

Rasmussen's encephalitis (RE) is a childhood epilepsy syndrome characterized by drug-refractory focal seizures especially epilepsia partialis continua, progressive hemiparesis, and neurocognitive decline. Diagnosis is mainly clinical and can be ambiguous during the early stages of the disease. Its underlying etiology is still elusive, but is suspected to be immune mediated. Treatment of seizures and disease progression is challenging, and although immunotherapy may delay its course, to date, surgical disconnection of the diseased hemisphere remains to be the only effective treatment providing seizure freedom in 60 to 85% of cases. The following review summarizes the current knowledge of the pathophysiology, clinical presentation, management, and treatment of RE.

Keywords

Rasmussen's encephalitis - surgery - immunotherapy

Volltext

Referenzen

References
1 Rasmussen T, Olszewski J, Lloydsmith D. Focal seizures due to chronic localized encephalitis. Neurology 1958; 8 (06) 435-445
2 Bien CG, Tiemeier H, Sassen R. , et al. Rasmussen encephalitis: incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins. Epilepsia 2013; 54 (03) 543-550
3 Bien CG, Granata T, Antozzi C. , et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005; 128 (Pt 3): 454-471
4 Robitaille Y. Neuropathologic aspects of chronic encephalitis. In: Andermann F. , ed. Chronic Encephalitis and Epilepsy. Rasmussen's Syndrome. Boston: Butterworth-Heinemann; 1991: 79-110
5 Bien CG, Bauer J, Deckwerth TL. , et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002; 51 (03) 311-318
6 Pardo CA, Vining EP, Guo L, Skolasky RL, Carson BS, Freeman JM. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia 2004; 45 (05) 516-526
7 Li Y, Uccelli A, Laxer KD. , et al. Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol 1997; 158 (03) 1428-1437
8 Schwab N, Bien CG, Waschbisch A. , et al. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 2009; 132 (Pt 5): 1236-1246
9 Walter GF, Renella RR. Epstein-Barr virus in brain and Rasmussen's encephalitis. Lancet 1989; 1 (8632): 279-280
10 Power C, Poland SD, Blume WT, Girvin JP, Rice GP. Cytomegalovirus and Rasmussen's encephalitis. Lancet 1990; 336 (8726): 1282-1284
11 Jay V, Becker LE, Otsubo H. , et al. Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology 1995; 45 (01) 108-117
12 Vinters HV, Wang R, Wiley CA. Herpesviruses in chronic encephalitis associated with intractable childhood epilepsy. Hum Pathol 1993; 24 (08) 871-879
13 Rogers SW, Andrews PI, Gahring LC. , et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994; 265 (5172): 648-651
14 Mantegazza R, Bernasconi P, Baggi F. , et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 2002; 131 (1–2): 179-185
15 Watson R, Jiang Y, Bermudez I. , et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 2004; 63 (01) 43-50
16 Watson R, Jepson JE, Bermudez I. , et al. Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis. Neurology 2005; 65 (11) 1802-1804
17 Yang R, Puranam RS, Butler LS. , et al. Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron 2000; 28 (02) 375-383
18 Alvarez-Barón E, Bien CG, Schramm J, Elger CE, Becker AJ, Schoch S. Autoantibodies to Munc18, cerebral plasma cells and B-lymphocytes in Rasmussen encephalitis. Epilepsy Res 2008; 80 (01) 93-97
19 Pardo CA, Nabbout R, Galanopoulou AS. Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES). Neurotherapeutics 2014; 11 (02) 297-310
20 Wirenfeldt M, Clare R, Tung S, Bottini A, Mathern GW, Vinters HV. Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex. Neurobiol Dis 2009; 34 (03) 432-440
21 Banati RB, Goerres GW, Myers R. , et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 1999; 53 (09) 2199-2203
22 Ramaswamy V, Walsh JG, Sinclair DB. , et al. Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis. J Neuroinflammation 2013; 10: 152
23 Maroso M, Balosso S, Ravizza T. , et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010; 16 (04) 413-419
24 Luan G, Gao Q, Zhai F, Chen Y, Li T. Upregulation of HMGB1, toll-like receptor and RAGE in human Rasmussen's encephalitis. Epilepsy Res 2016; 123: 36-49
25 Chin JH. Adenosine receptors in brain: neuromodulation and role in epilepsy. Ann Neurol 1989; 26 (06) 695-698
26 Luan G, Wang X, Gao Q. , et al. Upregulation of neuronal adenosine A1 receptor in human Rasmussen encephalitis. J Neuropathol Exp Neurol 2017; 76 (08) 720-731
27 Luan G, Gao Q, Guan Y. , et al. Upregulation of adenosine kinase in Rasmussen encephalitis. J Neuropathol Exp Neurol 2013; 72 (11) 1000-1008
28 Oguni HAF, Rasmussen TB. The natural history of the syndrome of chronic encephalitis and epilepsy: a study of the MNI series of fourty-eight cases. In: Andermann F. , ed. Chronic Encephalitis and Epilepsy. Boston: Butterworth-Heinemann; 1991: 7-35
29 Villani F, Pincherle A, Antozzi C. , et al. Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases. Epilepsia 2006; 47 (Suppl. 05) 41-46
30 Dupont S, Gales A, Sammey S, Vidailhet M, Lambrecq V. Late-onset Rasmussen Encephalitis: A literature appraisal. Autoimmun Rev 2017; 16 (08) 803-810
31 Hart YM, Andermann F, Fish DR. , et al. Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen's syndrome?. Neurology 1997; 48 (02) 418-424
32 Jaillon-Riviere V, Dupont S, Bertran F. , et al. Late onset Rasmussen's syndrome: clinical and therapeutic characteristics [Article in French]. Rev Neurol (Paris) 2007; 163 (05) 573-580
33 Bien CG, Widman G, Urbach H. , et al. The natural history of Rasmussen's encephalitis. Brain 2002; 125 (Pt 8): 1751-1759
34 Granata T, Gobbi G, Spreafico R. , et al. Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology 2003; 60 (03) 422-425
35 Hennessy MJ, Koutroumanidis M, Dean AF. , et al. Chronic encephalitis and temporal lobe epilepsy: a variant of Rasmussen's syndrome?. Neurology 2001; 56 (05) 678-681
36 Bien CG, Elger CE, Leitner Y. , et al. Slowly progressive hemiparesis in childhood as a consequence of Rasmussen encephalitis without or with delayed-onset seizures. Eur J Neurol 2007; 14 (04) 387-390
37 Ravindra VM, Mazur MD, Mohila CA, Sweney MT, Hersh A, Bollo RJ. Rasmussen encephalitis with dual pathology in a patient without seizures: case report and literature review. Childs Nerv Syst 2015; 31 (11) 2165-2171
38 Frucht S. Dystonia, athetosis, and epilepsia partialis continua in a patient with late-onset Rasmussen's encephalitis. Mov Disord 2002; 17 (03) 609-612
39 Chiapparini L, Granata T, Farina L. , et al. Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis?. Neuroradiology 2003; 45 (03) 171-183
40 Bien CG, Urbach H, Deckert M. , et al. Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology. Neurology 2002; 58 (02) 250-257
41 Fiorella DJ, Provenzale JM, Coleman RE, Crain BJ, Al-Sugair AA. (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. Am J Neuroradiol 2001; 22 (07) 1291-1299
42 Kuki I, Matsuda K, Kubota Y. , et al. Functional neuroimaging in Rasmussen syndrome. Epilepsy Res 2018; 140: 120-127
43 Mameniškienė R, Wolf P. Epilepsia partialis continua: a review. Seizure 2017; 44: 74-80
44 Longaretti F, Dunkley C, Varadkar S, Vargha-Khadem F, Boyd SG, Cross JH. Evolution of the EEG in children with Rasmussen's syndrome. Epilepsia 2012; 53 (09) 1539-1545
45 Rossi Sebastiano D, Visani E, Duran D. , et al. Epileptic spikes in Rasmussen's encephalitis: migratory pattern and short-term evolution. A MEG study. Clin Neurophysiol 2017; 128 (10) 1898-1905
46 Kravljanac R, Djuric M, Jovic N, Djordjevic M, Zamurovic D, Pekmezovic T. Etiology, clinical features and outcome of epilepsia partialis continua in cohort of 51 children. Epilepsy Res 2013; 104 (1–2): 112-117
47 Joe B, Goldsmith I, Yoshor D, Verma A. Successful treatment of epilepsia partialis continua by partial focal resection in a patient with Sturge-Weber syndrome. J Clin Neurophysiol 2005; 22 (05) 358
48 Cornelius LP, Raju V, Lalapet RA. A case of epilepsia partialis continua due to linear nevus syndrome with hemimegalencephaly. J Pediatr Neurosci 2017; 12 (02) 203-205
49 Daghistani R, Widjaja E. Role of MRI in patient selection for surgical treatment of intractable epilepsy in infancy. Brain Dev 2013; 35 (08) 697-705
50 Wolf NI, Rahman S, Schmitt B. , et al. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 2009; 50 (06) 1596-1607
51 Cohen BHCP, Copeland WC. POLG-Related Disorders. 2010; Available at: https://www-ncbi-nlm-nih-gov.proxy.lib.wayne.edu/books/NBK26471/ . Accessed May 5, 2018
52 Gastaut H, Faidherbe J, Roger J. [5 case reports of unusual development of the hemiconvulsion-hemiplegiaepilepsy syndrome (HHE syndrome) in children]. Acta Neurol Psychiatr Belg 1962; 62: 177-192
53 Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011; 10 (01) 99-108
54 Freeman JL, Coleman LT, Smith LJ, Shield LK. Hemiconvulsion-hemiplegia-epilepsy syndrome: characteristic early magnetic resonance imaging findings. J Child Neurol 2002; 17 (01) 10-16
55 Longo D, Paonessa A, Specchio N. , et al. Parry-Romberg syndrome and Rasmussen encephalitis: possible association. Clinical and neuroimaging features. J Neuroimaging 2011; 21 (02) 188-193
56 Shah JR, Juhász C, Kupsky WJ. , et al. Rasmussen encephalitis associated with Parry-Romberg syndrome. Neurology 2003; 61 (03) 395-397
57 El-Kehdy J, Abbas O, Rubeiz N. A review of Parry-Romberg syndrome. J Am Acad Dermatol 2012; 67 (04) 769-784
58 Paprocka J, Jamroz E, Adamek D, Marszal E, Mandera M. Difficulties in differentiation of Parry-Romberg syndrome, unilateral facial sclerodermia, and Rasmussen syndrome. Childs Nerv Syst 2006; 22 (04) 409-415
59 Olson HE, Lechpammer M, Prabhu SP. , et al. Clinical application and evaluation of the Bien diagnostic criteria for Rasmussen encephalitis. Epilepsia 2013; 54 (10) 1753-1760
60 Grujic J, Bien CG, Pollo C, Rossetti AO. Vagus nerve stimulator treatment in adult-onset Rasmussen's encephalitis. Epilepsy Behav 2011; 20 (01) 123-125
61 San-Juan D, Calcáneo JdeD, González-Aragón MF. , et al. Transcranial direct current stimulation in adolescent and adult Rasmussen's encephalitis. Epilepsy Behav 2011; 20 (01) 126-131
62 Kang JS, Krakow K, Roggendorf J, Steinmetz H, Hilker R. Botulinum toxin treatment of epilepsia partialis continua. Mov Disord 2009; 24 (01) 141-143
63 Lozsadi DA, Hart IK, Moore AP. Botulinum toxin A improves involuntary limb movements in Rasmussen syndrome. Neurology 2004; 62 (07) 1233-1234
64 Bien CG, Schramm J. Treatment of Rasmussen encephalitis half a century after its initial description: promising prospects and a dilemma. Epilepsy Res 2009; 86 (2–3): 101-112
65 Varadkar S, Bien CG, Kruse CA. , et al. Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol 2014; 13 (02) 195-205
66 Vining EP, Freeman JM, Pillas DJ. , et al. Why would you remove half a brain? The outcome of 58 children after hemispherectomy-the Johns Hopkins experience: 1968 to 1996. Pediatrics 1997; 100 (2 Pt 1): 163-171
67 Lettori D, Battaglia D, Sacco A. , et al. Early hemispherectomy in catastrophic epilepsy: a neuro-cognitive and epileptic long-term follow-up. Seizure 2008; 17 (01) 49-63
68 Granata T, Andermann F. Rasmussen encephalitis. Handb Clin Neurol 2013; 111: 511-519
69 Honavar M, Janota I, Polkey CE. Rasmussen's encephalitis in surgery for epilepsy. Dev Med Child Neurol 1992; 34 (01) 3-14
70 Rasmussen T. Hemispherectomy for seizures revisited. Can J Neurol Sci 1983; 10 (02) 71-78
71 Hartman AL, Cross JH. Timing of surgery in rasmussen syndrome: is patience a virtue?. Epilepsy Curr 2014; 14 (1, Suppl): 8-11
72 Granata T, Fusco L, Gobbi G. , et al. Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology 2003; 61 (12) 1807-1810
73 Chinchilla D, Dulac O, Robain O. , et al. Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids. J Neurol Neurosurg Psychiatry 1994; 57 (11) 1325-1333
74 Hart YM, Cortez M, Andermann F. , et al. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology 1994; 44 (06) 1030-1036
75 Bahi-Buisson N, Villanueva V, Bulteau C. , et al. Long term response to steroid therapy in Rasmussen encephalitis. Seizure 2007; 16 (06) 485-492
76 Leach JP, Chadwick DW, Miles JB, Hart IK. Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy. Neurology 1999; 52 (04) 738-742
77 Takahashi Y, Yamazaki E, Mine J. , et al. Immunomodulatory therapy versus surgery for Rasmussen syndrome in early childhood. Brain Dev 2013; 35 (08) 778-785
78 Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO. Plasmapheresis in Rasmussen's encephalitis. Neurology 1996; 46 (01) 242-246
79 Antozzi C, Granata T, Aurisano N. , et al. Long-term selective IgG immuno-adsorption improves Rasmussen's encephalitis. Neurology 1998; 51 (01) 302-305
80 Bien CG, Gleissner U, Sassen R, Widman G, Urbach H, Elger CE. An open study of tacrolimus therapy in Rasmussen encephalitis. Neurology 2004; 62 (11) 2106-2109
81 Derry C, Dale RC, Thom M, Miller DH, Giovannoni G. Unihemispheric cerebral vasculitis mimicking Rasmussen's encephalitis. Neurology 2002; 58 (02) 327-328